CLOSTRIDIA DIFFICILE COLITIS

Clinical trials for CLOSTRIDIA DIFFICILE COLITIS explained in plain language.

Never miss a new study

Get alerted when new CLOSTRIDIA DIFFICILE COLITIS trials appear

Sign up with your email to follow new studies for CLOSTRIDIA DIFFICILE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New study aims to outsmart recurring c. diff infections

Disease control Recruiting now

This study compares two treatments to prevent Clostridioides difficile (C. diff) infection from returning. About 500 adults with a first or second C. diff episode will receive either a vancomycin taper or a 10-day course of fidaxomicin. The goal is to see if the vancomycin taper …

Matched conditions: CLOSTRIDIA DIFFICILE COLITIS

Phase: PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control

Last updated May 17, 2026 02:07 UTC

CLOSTRIDIA DIFFICILE COLITIS

Get alerted when new CLOSTRIDIA DIFFICILE COLITIS trials appear

New study aims to outsmart recurring c. diff infections